New method of diagnosis and treatment of breast cancer

The method of accurately determining Her2nu's expression in breast cancer greatly reduces the cost of treating and protecting the health of patients.

On May 12, the Oncology Hospital has just released a molecular cell biology laboratory using the Fish method (in situ hybridization with fluorescence) to help determine the exact manifestations of Her2nu gene which are negative or positive calculated, to help predict the course of the disease to provide appropriate treatment.

In the past, when breast cancer patients were detected, doctors would use immunohistochemistry to diagnose Her2nu's manifestations or send specimens to Malaysia to determine accurately (cost about 4 million VND). ), because not all breast cancer patients have Her2nu gene expression.

Operating Her2nu's diagnostic system of manifestations.Photo: Thu Thanh

However, immunohistochemistry has not yielded a high degree of diagnostic accuracy. If misdiagnosis can waste a lot of money and affect a patient's health.

Her2nu is considered a poor prognostic factor if it occurs in breast cancer and must be treated with Herceptin method (the cost of treatment of several hundred million). And the patient with breast cancer only used Herceptin when all the usual treatments (including radiotherapy) were meaningless.

Fish makes an accurate analysis of Her2nu's presence or not, helping doctors to make the right decisions about using targeted therapies to deliver efficacy, protect health, avoid wasting patients .

This new diagnostic period lasts about 48 hours with a price of about 2.5 million (1.5 million cheaper than sending specimens to Malaysia for determination).

Dr. Pham Xuan Dung - Deputy Director of Ho Chi Minh City Oncology Hospital said that this Herceptin method will be applied to some other diseases such as HBV diagnosis in the treatment of cervical cancer and stomach cancer. … next time.